Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Denmark's Leo Pharma Delays IPO Plans Beyond 2026, CEO Says
Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year. The Danish drugmaker, which specializes in treatments for skin conditions, is “ready” for an…
Big Pharma's race to stop Alzheimer's before it starts
Carole Greig was working as a companion to women living with dementia when she began to experience problems with her own short-term memory. The 71-year-old former bank employee was herself diagnosed with Alzheimer's disease in 2023: a terrible…
Which Healthcare ETF Is the Better Buy: VanEck's Pharma Fund PPH or iShares' Biotech Fund IBB?
Investors choosing between VanEck Pharmaceutical ETF (PPH +1.11%) and iShares Biotechnology ETF (IBB -0.44%) are weighing a concentrated, dividend-paying basket of drugmakers against a broader, more volatile portfolio of biotech innovators. The…
Which Healthcare ETF Is the Better Buy: State Street's Pharma Fund XPH or iShares' Biotech Fund IBB?
State Street SPDR S&P Pharmaceuticals ETF (XPH -0.28%) and iShares Biotechnology ETF (IBB -0.44%) both offer targeted healthcare exposure, but they differ significantly in sub-sector focus, asset size, and cost structure. Healthcare investors often…
FY2026 EPS Estimate for Spyglass Pharma Decreased by Analyst
Spyglass Pharma, Inc. (NASDAQ:SGP - Free Report) - Analysts at HC Wainwright decreased their FY2026 earnings per share (EPS) estimates for Spyglass Pharma in a research note issued on Thursday, November 12th. HC Wainwright analyst Y. Chen now…
Avalyn Pharma (NASDAQ:AVLN) Stock Gets Price Target Trim from Morgan Stanley
Avalyn Pharma (NASDAQ:AVLN - Get Free Report) had its price target dropped by equities researchers at Morgan Stanley from $57.00 to $53.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has an…
Ascendis Pharma A/S (NASDAQ:ASND) Stock Price Expected to Rise, Barclays Analyst Says
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) had its price target upped by stock analysts at Barclays from $329.00 to $341.00 in a research note issued to investors on Monday, Benzinga reports. The firm presently has an 'overweight' rating…
310,727 Royalty Pharma PLC $RPRX Shares Sold by Alps Advisors Inc.
Alps Advisors Inc. trimmed its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 98.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor…
Royalty Pharma PLC $RPRX Stock: Danske Bank A S Grows Position
Danske Bank A S grew its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 44.4% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 1,107,117 shares of the biopharmaceutical…
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Sees Large Decrease in Short Interest
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) was the target of a significant decrease in short interest in October. As of October 30th, there was short interest totaling 9,125 shares, a decrease of 49.8%…
Spyglass Pharma, Inc. (NASDAQ:SGP) Stock Rated 'Moderate Buy' by Wall Street Brokerages
Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) has been assigned an average rating of 'Moderate Buy' from the nine analysts that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell…
Ascendis Pharma A/S (NASDAQ:ASND) Stock Has Consensus Price Target of $313.52
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) has received an average recommendation of 'Moderate Buy' from the twenty-one analysts that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a…
Telangana government urged to clear fee reimbursement dues of pharmacy colleges
The Telangana Pharmacy Colleges Managements Association, comprising 120 private colleges and 3 government colleges, with approximately 70,000 students, has urged the government to clear the fee reimbursement dues that are meagre compared to others.
The Stock Market Is Doing Something Witnessed Only 2 Times in 155 Years -- and History Is Crystal Clear About What Happens Next.
The S&P 500 galloped higher over the past three calendar years, climbing 78%, and generally carried the momentum into 2026. Investors were excited about the development of artificial intelligence (AI) and rushed to get in on early winners in the…
Better Healthcare ETF: Invesco's PJP vs. Simplify's PINK
Comparing the Simplify Health Care ETF (PINK +0.13%) and Invesco Pharmaceuticals ETF (PJP +0.41%) reveals distinct approaches to healthcare, with PINK focusing on broad innovation through active management and PJP offering concentrated exposure to…
Receive a Daily briefing on Pharma Industry News
Get Started